Sit Investment Associates’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-16,624
| Closed | -$497K | – | 536 |
|
|
2025
Q3 | $497K | Hold |
16,624
| – | – | 0.01% | 411 |
|
|
2025
Q2 | $494K | Hold |
16,624
| – | – | 0.01% | 417 |
|
|
2025
Q1 | $508K | Hold |
16,624
| – | – | 0.01% | 410 |
|
|
2024
Q4 | $658K | Hold |
16,624
| – | – | 0.01% | 408 |
|
|
2024
Q3 | $645K | Hold |
16,624
| – | – | 0.01% | 414 |
|
|
2024
Q2 | $699K | Hold |
16,624
| – | – | 0.02% | 388 |
|
|
2024
Q1 | $488K | Hold |
16,624
| – | – | 0.01% | 410 |
|
|
2023
Q4 | $604K | Hold |
16,624
| – | – | 0.01% | 397 |
|
|
2023
Q3 | $533K | Hold |
16,624
| – | – | 0.01% | 391 |
|
|
2023
Q2 | $520K | Hold |
16,624
| – | – | 0.01% | 413 |
|
|
2023
Q1 | $379K | Hold |
16,624
| – | – | 0.01% | 429 |
|
|
2022
Q4 | $567K | Hold |
16,624
| – | – | 0.02% | 390 |
|
|
2022
Q3 | $505K | Hold |
16,624
| – | – | 0.02% | 391 |
|
|
2022
Q2 | $619K | Hold |
16,624
| – | – | 0.02% | 370 |
|
|
2022
Q1 | $754K | Hold |
16,624
| – | – | 0.02% | 376 |
|
|
2021
Q4 | $800K | Hold |
16,624
| – | – | 0.02% | 383 |
|
|
2021
Q3 | $924K | Hold |
16,624
| – | – | 0.02% | 360 |
|
|
2021
Q2 | $902K | Hold |
16,624
| – | – | 0.02% | 371 |
|
|
2021
Q1 | $932K | Hold |
16,624
| – | – | 0.02% | 364 |
|
|
2020
Q4 | $723K | Buy |
+16,624
| New | +$654K | 0.02% | 375 |
|
Other funds holding SRDX
Sit Investment Associates's SRDX Position: Q4 2025 in Review
Sit Investment Associates sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 16,624 shares — an estimated $497K sold.
Sit Investment Associates first reported a position in SRDX in Q4 2020 and held it in 20 quarters. The position peaked at $932K in Q1 2021. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Sit Investment Associates reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Sit Investment Associates sold 16,624 Surmodics shares in Q4 2025, an estimated $497K.
- Sit Investment Associates first reported a position in Surmodics in Q4 2020 and held it in 20 quarters.
- Sit Investment Associates's Surmodics position peaked at $932K in Q1 2021.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Sit Investment Associates's 13F filing for Q4 2025, filed 12 Feb 2026.